Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

ClinicalTrials.gov ID: NCT00828009

Public ClinicalTrials.gov record NCT00828009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 3:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of L-BLP25 and Bevacizumab in Unresectable Stage IIIA and IIIB Non-Squamous Non-Small Cell Lung Cancer After Definitive Chemoradiation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving vaccine therapy together with bevacizumab after chemotherapy and radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying the side effects of giving BLP25 liposome vaccine together with bevacizumab after chemotherapy and radiation therapy in treating patients with newly diagnosed stage IIIA or stage IIIB non-small cell lung cancer that cannot be removed by surgery.

Study identification

NCT ID
NCT00828009
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
70 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 17, 2011 (Actual)
Primary completion
Aug 20, 2018 (Actual)
Completion
May 22, 2019 (Actual)
Last update posted
Jul 7, 2023

2011 – 2019

United States locations

U.S. sites
88
U.S. states
16
U.S. cities
64
Facility City State ZIP Site status
Veterans Affairs Medical Center - Palo Alto Palo Alto California 94304 —
Stanford Cancer Center Stanford California 94305-5824 —
Medical Center of Central Georgia Macon Georgia 31208 —
St. Joseph Medical Center Bloomington Illinois 61701 —
Graham Hospital Canton Illinois 61520 —
Memorial Hospital Carthage Illinois 62321 —
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611-3013 —
Hematology and Oncology Associates Chicago Illinois 60611 —
Saint Joseph Hospital Chicago Illinois 60657 —
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526 —
Eureka Community Hospital Eureka Illinois 61530 —
Galesburg Clinic, PC Galesburg Illinois 61401 —
Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey Illinois 60426 —
Mason District Hospital Havana Illinois 62644 —
Kellogg Cancer Care Center Highland Park Illinois 60035 —
Hinsdale Hematology Oncology Associates Hinsdale Illinois 60521 —
Provena St. Mary's Regional Cancer Center - Kankakee Kankakee Illinois 60901 —
North Shore Oncology and Hematology Associates, Limited - Libertyville Libertyville Illinois 60048 —
McDonough District Hospital Macomb Illinois 61455 —
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus Moline Illinois 61265 —
Cancer Care and Hematology Specialists of Chicagoland - Niles Niles Illinois 60714 —
BroMenn Regional Medical Center Normal Illinois 61761 —
Community Cancer Center Normal Illinois 61761 —
Community Hospital of Ottawa Ottawa Illinois 61350 —
Cancer Treatment Center at Pekin Hospital Pekin Illinois 61554 —
Proctor Hospital Peoria Illinois 61614 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61615 —
Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria Illinois 61615 —
Methodist Medical Center of Illinois Peoria Illinois 61636 —
OSF St. Francis Medical Center Peoria Illinois 61637 —
Illinois Valley Community Hospital Peru Illinois 61354 —
Perry Memorial Hospital Princeton Illinois 61356 —
Swedish-American Regional Cancer Center Rockford Illinois 61104-2315 —
Hematology Oncology Associates - Skokie Skokie Illinois 60076 —
Regional Cancer Center at Memorial Medical Center Springfield Illinois 62781-0001 —
Elkhart General Hospital Elkhart Indiana 46515 —
Howard Community Hospital Kokomo Indiana 46904 —
Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana 46350 —
Saint Joseph Regional Medical Center Mishawaka Indiana 46545-1470 —
Cancer Center at Ball Memorial Hospital Muncie Indiana 47303-3499 —
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601 —
Memorial Hospital of South Bend South Bend Indiana 46601 —
McFarland Clinic, PC Ames Iowa 50010 —
Medical Oncology and Hematology Associates - West Des Moines Clive Iowa 50325 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309 —
John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines Iowa 50309 —
Medical Oncology and Hematology Associates at John Stoddard Cancer Center Des Moines Iowa 50309 —
Medical Oncology and Hematology Associates at Mercy Cancer Center Des Moines Iowa 50314 —
Mercy Cancer Center at Mercy Medical Center - Des Moines Des Moines Iowa 50314 —
John Stoddard Cancer Center at Iowa Lutheran Hospital Des Moines Iowa 50316 —
Siouxland Hematology-Oncology Associates, LLP Sioux City Iowa 51101 —
Mercy Medical Center - Sioux City Sioux City Iowa 51102 —
St. Luke's Regional Medical Center Sioux City Iowa 51104 —
Tufts Medical Center Cancer Center Boston Massachusetts 02111 —
Borgess Medical Center Kalamazoo Michigan 49001 —
West Michigan Cancer Center Kalamazoo Michigan 49007-3731 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan 49085 —
Lakeside Cancer Specialists, PLLC Saint Joseph Michigan 49085 —
Cancer Resource Center - Lincoln Lincoln Nebraska 68510 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Immanuel Medical Center Omaha Nebraska 68122 —
Alegant Health Cancer Center at Bergan Mercy Medical Center Omaha Nebraska 68124 —
Lakeside Hospital Omaha Nebraska 68130 —
Creighton University Medical Center Omaha Nebraska 68131-2197 —
Cancer Institute of New Jersey at Hamilton Hamilton New Jersey 08690 —
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick New Jersey 08903 —
Stony Brook University Cancer Center Stony Brook New York 11794-9446 —
Mercy Cancer Center at Mercy Medical Center Canton Ohio 44708 —
Case Comprehensive Cancer Center Cleveland Ohio 44106-5065 —
St. Rita's Medical Center Lima Ohio 45801 —
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown Pennsylvania 18105 —
Geisinger Cancer Institute at Geisinger Health Danville Pennsylvania 17822-0001 —
PinnacleHealth Regional Cancer Center at Polyclinic Hospital Harrisburg Pennsylvania 17110-2098 —
Geisinger Hazleton Cancer Center Hazleton Pennsylvania 18201 —
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Lewistown Hospital Lewistown Pennsylvania 17044 —
Pottstown Memorial Regional Cancer Center Pottstown Pennsylvania 19464 —
Geisinger Medical Group - Scenery Park State College Pennsylvania 16801 —
Mount Nittany Medical Center State College Pennsylvania 16803 —
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center Wilkes-Barre Pennsylvania 18711 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 —
Parkland Memorial Hospital Dallas Texas 75235 —
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas 75390 —
West Virginia University Health Sciences Center - Charleston Charleston West Virginia 25304 —
Gundersen Lutheran Center for Cancer and Blood La Crosse Wisconsin 54601 —
Regional Cancer Center at Oconomowoc Memorial Hospital Oconomowoc Wisconsin 53066 —
Waukesha Memorial Hospital Regional Cancer Center Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00828009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2023 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00828009 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →